Montest 4 MG Tablet

Montest 4 MG Tablet is used to treat asthma, hay fever and seasonal allergy symptoms. It prevents asthma attacks and breathing problems caused by exercise. This medciine is used for prophylaxis and chronic treatment of asthma in adults and children greater than or equal to 2 years of age.

This medication belongs to the class of a leukotriene receptor antagonist and works by blocking leukotriene that causes allergic reactions in the body. It selectively blocks the action of this chemical in the body.

Before using this medicine inform your doctor if you are or have any of the following conditions :

• Allergic to any of its ingredients or to any medicines, food and other substances.
• Pregnant, planning to be pregnant, or are breast-feeding.
• Taking any dietary supplement, herbal preparation, or other prescribed medicines.
• History of alcoholism or liver problems.
• Mental problems or mood swings including depression, suicidal thoughts, etc.
• If you are lactose intolerant.
• Taking a corticosteroid and are planning to stop or lower the dose.

Montest 4 MG Tablet is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus. It should not be used as monotherapy for the treatment and management of exercise-induced bronchospasm. Advise patients to have appropriate rescue medication available.

Appropriate clinical monitoring and caution are recommended when systemic corticosteroid reduction is considered in patients receiving montelukast. Inform phenylketonuric patients that the chewable tablet contains phenylalanine 0.842 mg/5 mg chewable tablet.

In rare cases, patients on therapy with montelukast may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with Churg-Strauss syndrome, a condition which is often treated with systemic corticosteroid therapy.

Physicians should be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. A casual association between montelukast and these underlying conditions has not been established.

This medication is not for an acute asthmatic attack; in acute attack, follow instructions of prescriber. Do not stop other asthma medication unless advised by prescriber.

Take every evening on a continuous basis; do not discontinue even if feeling better (this medication may help reduce incidence of acute attacks).

You may experience mild headache (mild analgesic may help); fatigue or dizziness (use caution when driving). Report skin rash or itching, abdominal pain or persistent GI upset, unusual cough or congestion, or worsening of asthmatic condition.

Montest 4 MG Tablet is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus. Should not be used as monotherapy for the treatment and management of exercise-induced bronchospasm. Advise patients to have appropriate rescue medication available.

Appropriate clinical monitoring and caution are recommended when systemic corticosteroid reduction is considered in patients receiving montelukast. Inform phenylketonuric patients that the chewable tablet contains phenylalanine 0.842 mg/5 mg chewable tablet.

The medication can treat the below provided problems:

• Asthma

  This medication is used for the prevention and maintenance of asthma. This medicine also helps in relieving the symptoms of chronic asthma.

• Allergic Rhinitis

  This medication is used for relieving the symptoms of allergic rhinitis. The allergic condition could be seasonal or non-seasonal and long lasting.

• Bronchospasm

  This medication is also used for the prevention of sudden narrowing of airways, which can cause breathing difficulties. This medicine is used mostly for exercise-induced bronchospasm.

• Allergy

  This medicine is not recommended for use if you have a history of allergy to this medication or any other component present with it in the dosage form.

A patient can suffer from the following side effects:

• Headache

• Dizziness

• Fatigue

• Fever

• Rash

• Dyspepsia

• Dental Pain

• Diarrhoea

• Nausea

• Weakness

• Cough

• Nasal Congestion

• How long is the duration of effect?

  The effect of this medicine lasts for an average duration of 24 hours.

• What is the onset of action?

  The effect of this medicine can be observed after 1-3 hours of administration.

• Are there any pregnancy warnings?

  Use of this medicine in pregnant women should be avoided unless clearly needed.

• Is it habit forming?

  No habit forming tendencies were reported.

• Are there any breast-feeding warnings?

  Use of this medicine should be avoided unless clearly needed.

• Does this affect kidney function?

  Reaction of Montest 4 MG Tablet on the kidney is not known. If anyone is already suffering from kidney related troubles, it is essential to seek medical help before consuming the medicine.

• Does this affect liver function?

  For patients suffering from mild to moderate liver ailments it is necessary to exercise caution before taking Montest 4 MG Tablet. It is necessary to consult the physician in such circumstances.

• Is It safe with alcohol?

  It is advisable for the patient to reduce or discontinue consumption of alcohol while on this medicine. Any abnormal reactions should be reported to the doctor without delay.

• Is it safe to drive while on this medicine?

  This medicine may make one feel sleepy and dizzy. Therefore it is recommended not to drive in such a condition.

Below is the list of medicines, which have the same composition, strength and form as Montest 4 MG Tablet , and hence can be used as its substitute.

• Singulair 4 MG Tablet

  Msd Pharmaceuticals Private Ltd.

• Emlucast 4 MG Tablet

  Dr. Reddys Laboratories Ltd

• Montina 4 MG Tablet

  Aristo Pharmaceuticals Pvt.Ltd

• Montair 4 MG Tablet

  Cipla Ltd

• Kefage 250 MG Injection

  Indchemie Health Specialities Pvt. Ltd

• Missed Dose instructions

  Take the missed dose as soon as you remember. The missed dose should be skipped if it is almost time for the next scheduled dose.

• Are there any overdose instructions?

  Contact your doctor if an overdose is suspected. Symptoms may include stomach pain, sleeplessness, vomiting, and agitation.

• India

• United States

• Japan

This medication belongs to the class of chemical that causes allergic reactions in the body. This medicine selectively blocks the action of this chemical in the body.

Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction.

• Interaction with Alcohol

  You are advised to restrict or minimize the consumption of alcohol while using this medicine. Report any unwanted effects to the doctor on priority.

• Interaction with Medicine

  Carbamazepine

  Report the use of either of the medicines to the doctor. You may require an adjusted dose and safety monitoring while taking these medicines together. Contact your doctor if your symptoms get worse or you experience some side effects.

  Fluconazole

  Report the use of either of the medicines to the doctor. You may require an adjusted dose and safety monitoring while taking these medicines together. Contact your doctor if your symptoms get worse or you experience some side effects like headache, fever, sore throat etc.

  Phenytoin

  Report the use of either of the medicines to the doctor. You may require an adjusted dose and safety monitoring while taking these medicines together. Contact your doctor if your symptoms get worse or you experience some side effects.

  Phenobarbital

  Report the use of either of the medicines to the doctor. You may require an adjusted dose and safety monitoring while taking these medicines together. Contact your doctor if your symptoms get worse or you experience some side effects.

• Interaction with Disease

  Liver Disease

  Report the incidence of a liver disease or impaired liver function to the doctor before receiving this medicine. Clinical safety monitoring may be required if the impairment is severe. Caution is advised for patients having mild to moderate liver impairment.

• Interaction with Food

  Information not available.